| Long noncoding RNA (lincRNA), a new paradigm in gene expression control E Deniz, B Erman Functional & Integrative Genomics, 1-9, 2016 | 228 | 2016 |
| PATZ1 is a DNA damage-responsive transcription factor that inhibits p53 function N Keskin, E Deniz, J Eryilmaz, M Un, T Batur, T Ersahin, R Cetin Atalay, ... Molecular and cellular biology 35 (10), 1741-1753, 2015 | 34 | 2015 |
| Screening of new antileukemic agents from essential oils of algae extracts and computational modeling of their interactions with intracellular signaling nodes B Atasever-Arslan, K Yilancioglu, Z Kalkan, AC Timucin, H Gür, FB Isik, ... European Journal of Pharmaceutical Sciences 83, 120-131, 2016 | 32 | 2016 |
| CD8 lineage-specific regulation of interleukin-7 receptor expression by the transcriptional repressor Gfi1 DL Ligons, C Tuncer, BA Linowes, IM Akcay, S Kurtulus, E Deniz, ... Journal of Biological Chemistry 287 (41), 34386-34399, 2012 | 26 | 2012 |
| CD81 interacts with the T cell receptor to suppress signaling SI Cevik, N Keskin, S Belkaya, MI Ozlu, E Deniz, UH Tazebay, B Erman PloS one 7 (11), e50396, 2012 | 15 | 2012 |
| Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth B Somuncu, A Ekmekcioglu, FM Antmen, T Ertuzun, E Deniz, N Keskin, ... Plos one 17 (6), e0268391, 2022 | 4 | 2022 |
| Piperacetazine Directly Binds to the PAX3:: FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity K Nakazawa, T Shaw, YK Song, M Kouassi-Brou, A Molotkova, PB Tiwari, ... Cancer Research Communications 3 (10), 2030-2043, 2023 | 1 | 2023 |
| In vivo CRISPR/Cas9 transcriptional activation screen leads to discovery of INAFM2, a novel driver of metastasis A Molotkova, E Deniz, M Swift, E Glasgow, J Toretsky, A Üren Cancer Research 84 (6_Supplement), 1560-1560, 2024 | | 2024 |
| Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability K Balaraman, E Deniz, E Nelson, SL Pilicer, S Atasoy, A Molotkova, ... European Journal of Medicinal Chemistry 251, 115244, 2023 | | 2023 |
| Novel mechanisms of ezrin function in osteosarcoma metastasis. A Uren, E Deniz, T Shaw, J Toretsky, LO Penalva CLINICAL CANCER RESEARCH 28 (18), 10-11, 2022 | | 2022 |
| Abstract PR013: Novel mechanisms of ezrin function in osteosarcoma metastasis A Uren, E Deniz, T Shaw, J Toretsky, LO Penalva Clinical Cancer Research 28 (18_Supplement), PR013-PR013, 2022 | | 2022 |
| Editing of Long Noncoding RNA DANCR Gene Locus Using Genetic Engineering Tools G Baran, B Talug, N Keskin, ZT Keskin, B Erman, E Deniz 2017 21st National Biomedical Engineering Meeting (BIYOMUT), i-i, 2017 | | 2017 |
| Antileukemic Drug Potentials of Essential Oils of Algea Extracts BA Arslan, K Yilancioglu, Z Kalkan, VE Atalay, H Gur, FB Isik, E Deniz, ... ACTA PHYSIOLOGICA 215, 15-15, 2015 | | 2015 |
| Identification and characterization of small molecule inhibitors targeting DNA polymerase gamma for the treatment of cancers deficient in mismatch repair C Pamukcu, N Keskin, D Aydin, IE Gulser, E Deniz, MB Erman, B Erman, ... FEBS JOURNAL 282, 270-271, 2015 | | 2015 |
| The role of PATZ1 transcription factor in the DNA damage response E Deniz | | 2014 |
| Oral Communications BA Arslan, K Yılancıoğlu, Z Kalkan, VE Atalay, H Gür, FB Işık, E Deniz, ... | | |
